Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 111 - 120 of 394

Selected Filters:
12 October 2023

PrEP Ring Value Chain Situation Analysis – South Africa – 2021

This value chain situation analysis can support the introduction of the dapivirine ring in South Africa across two dimensions: considering and prioritizing delivery channels for the ring, and identifying critical steps for ring introduction, including opportunities to build on the introduction and scale-up of oral PrEP.

Normative Guidance/Policies, Service Delivery

Document
12 October 2023

Oral PrEP Value Chain Situation Analysis – Nigeria – 2020

This document provides a value chain situation analysis of oral PrEP in Nigeria as at June 2020.

Normative Guidance/Policies, Service Delivery

Document
11 October 2023

National Guidelines for Antiretroviral Therapy, 2019

The Ministry of Health and Social Services of Namibia has crafted these guidelines to spur the country toward ending the HIV epidemic by 2030. These guidelines are for all stakeholders involved in this effort.

Normative Guidance/Policies

Document
9 October 2023

Efficacy, Safety, Tolerability, and Pharmacokinetics of Long-acting Injectable Cabotegravir for HIV Pre-exposure Prophylaxis in Transgender Women: A secondary analysis of the HPTN 083 trial

This article from the Lancet HIV discusses the results of a secondary analysis of data from the HPTN 083 trial of cabotegravir for PrEP, looking specifically at the cohort of transgender women included in the study.

Research

External Link
25 September 2023

National HIV/AIDS Strategic Framework, 2017-2021

Zambia’s National HIV/AIDS Strategic Framework outlines the Zambian Ministry of Health’s commitment to ending the AIDS epidemic by 2030 and the UNAIDS Fast Track goals of achieving 90-90-90 treatment targets by 2020, with a focus on those most affected.

Normative Guidance/Policies

Document
25 September 2023

Consolidated Guidelines on Treatment & Prevention of HIV Infection, 2020

Zambia’s updated guidelines on HIV prevention and treatment present several recommendations on how to effectively prevent and treat HIV infection in the population.

Normative Guidance/Policies

Document
5 September 2023

Nigeria HIV Oral PrEP Job Aids & SOPs

See these job aids and SOPs for flow charts explaining the stages that PrEP clients go through, the role of a provider in this process, information on which documents will most smoothly allow providers to register patients on PrEP, guidance on vital service delivery points, and how to assess risk stratification of potential PrEP clients.

Service Delivery

Document
29 August 2023

Guidelines for HIV Prevention, Testing, and Treatment of HIV in Zimbabwe, 2022

The Zimbabwe Ministry of Health has created these guidelines to advise both private and public sector stakeholders on realigning and their initiatives to provide the best HIV care to clients in an effort to end AIDS by 2030. These guidelines are in line with the new Zimbabwe Health Sector HIV and STI Strategy: 2021-2025.

Normative Guidance/Policies

Document
29 August 2023

Technical Guidance on PrEP for Persons at Substantial Risk of HIV in Uganda, 2022

The Ministry of Health has created these technical guidelines to serve as guides for healthcare workers and stakeholders serving populations most at risk of acquiring HIV. These guidelines detail how to provide these populations with PrEP.

Normative Guidance/Policies

Document
29 August 2023

Changes in Relationships, HIV Risk, and Feelings towards PrEP: Findings from a qualitative explanatory study among participants in the CHARISMA intervention trial

This article from BMC Women’s Health explores women’s experiences with the CHARISMA randomized controlled trial, which tested whether the CHARISMA intervention mitigated relationship-based challenges to PrEP use, such as intimate partner violence, and looks into why the trial showed null results. Click here for more information on CHARISMA.

Research, Service Delivery

External Link